Recent Headlines
Peptineo Adds Dr. Yoganathan to Advisory Board to Strengthen Biomaterials Development and Commercialization
Dr. Yoganathan is a SME in the areas of biomaterials and drug delivery - having collaborated and worked closely with thought-leaders in the field such as Dr. Robert Langer, Dr. Kazunori Kataoka, Dr. Michael V. Sefton and Dr. Christine Allen. He is an expert in manipulating material properties to... - March 31, 2014 - Peptineo
Peptineo Announces Appointment of David M. Wyatt to Advisory Board
Peptineo is pleased to announce the appointment of David M. Wyatt to their advisory board. David has had over 25 years of technical and business experience in the development of controlled release pharmaceutical products. He has held senior management positions in sales and business development,... - March 27, 2014 - Peptineo
Dr. Sundar Nadarajan Joins the Advisory Board at Peptineo to Guide Nanotechnology Drug Delivery Platform for Protein Therapeutics
Sheldon K. Jordan, PhD, President and CEO, Peptineo, announces the appointment of Sundar Nadarajan, PhD, to the company's Scientific Advisory Board. They are extremely pleased that Dr. Nadarajan has joined the Peptineo Scientific Advisory Board. "He is an accomplished scientist and consulting... - March 27, 2014 - Peptineo
MoBiTec GmbH Offers MagSi-NGS/PREP Kit for Next Generation Sequencing (NGS) Library Clean-Up
Magnetic bead-based MagSi-NGS/PREP kit constitutes an efficient solution for clean-up and size selection in library preparation of NGS sequencing reactions. The simple, flexible protocol can be adjusted to any specific application and NGS platform. - March 27, 2014 - MoBiTec GmbH
Pioneers in Adult Stem Cell Therapy Honored
The Alliance for the Advancement of Adult Stem Cell Therapy and Research hosted an awards luncheon for doctors and patients from around the world to recognize and honor their outstanding contributions and achievements in adult stem cell therapy. The Stem Cell Alliance event celebrated the revolutionary strides in the field of adult stem cell treatments for cardiac, pulmonary, neurological, spinal cord injuries and vascular diseases. - March 26, 2014 - Regenocyte Worldwide
Exova Wins Major Defence Contract
Exova, the global testing, calibration and advisory services provider, has won a major contract with FMV, the Swedish Defence Material Administration, worth a potential £24.5 million over seven years. - March 21, 2014 - Exova
NeoStrata Canada Struts Runway-Ready Skin at World MasterCard Fashion Week
NeoStrata Canada teams up with high fashion as the Official Skin Care and Anti-Aging Treatments Sponsor of World MasterCard® Fashion Week (WMCFW) in Toronto, running from March 17 to 21. WMCFW attendees and beauty editors can visit the NeoStrata booth on site or access content, tips and... - March 15, 2014 - Sanofi Canada
Creative Biomart Launches New Services: Protein Labeling & Conjugation
Creative Biomart has announced the launch of a new offering for protein labeling and conjugation. - March 13, 2014 - Creative Biomart
CovalX and ASPEC Technologies Limited Announce Partnership for Distribution of CovalX’s High-Mass Systems in China
Providing the greater China region with sales, marketing and support to CovalX’s unique technologies for protein interaction and macromolecular analysis by mass spectrometry. - March 01, 2014 - CovalX
AnaSpec Now Offers 5-Hydroxymethyl Cytosine Monoclonal Antibody (Clone 4D9)
A mouse monoclonal antibody specifically recognizing 5-hydroxymethyl Cytosine (5-hmC) is now available from AnaSpec. - February 21, 2014 - AnaSpec, EGT Group
HeMemics Type C Meeting with FDA Blood Applications Division
HeMemics to meet with the FDA to discuss which of the available paths that HeMemics Platelet Additive Solution (HemSol™) may take in pursuit of FDA approval and commercialization - February 15, 2014 - HeMemics Biotech
HeMemics Announces Election of Larry Simpson to Its Board of Directors
Election of Larry Simpson to HeMemics Board of Directors - February 15, 2014 - HeMemics Biotech
Dr. Emil J. Haldey to Address Physicians in Field of Podiatric Medicine
Joint Session of American Board of Foot Surgeons and American Association of Medical Foot Specialists to welcome pharmaceutical compounding expert. - February 12, 2014 - HALDEY Pharmaceutical Compounding
SFL Experts to Present and Chair Sessions at the 2014 DIA Annual Euromeeting in Vienna
SFL experts will present on EU medical device/IVD law, public & regulatory affairs synergies and transparency of payments to the healthcare sector at 2014 DIA Annual EuroMeeting. - February 12, 2014 - SFL Regulatory Affairs & Scientific Communication Ltd
VIRUN® & Amway Open Innovation Push for More Creativity and Technology; Introducing Unknown Thoughts in Industry
Virun, and Amway Open Innovation, team-up to express their interest and efforts to foster creativity, invention, and innovation with foods, beverages and supplements. New product development is more difficult today than ever before; increased regulations, competition, market saturation and consumer perception make it difficult to introduce new products that, not only stand-out, but are what consumers will purchase and re-purchase. - February 11, 2014 - VIRUN
MoBiTec Offers CytoCapture-Cell Culture Dishes and Chambers for Single Cell Analysis of Small Non-Adherent Cells
CytoCapture dishes and chambers enable the analysis of small non-adherent cells, exposure studies with time dependent reactions, multiple staining and high resolution microscopy of non-adherent cells, and Laser Scanning Confocal Microscopy (LSM). - February 05, 2014 - MoBiTec GmbH
EightSpokes Announces the Launch of Their Online Presence
EightSpokes, creators of Enlighten, a SaaS-based commercial excellence platform designed with life science companies in mind, announces the launch of their online presence, EightSpokes.com. The website highlights the “Noble Eightfold Path” that inspired the company’s approach to make work more rewarding. Enlighten adopts proven social collaboration technologies and ideas from industry leaders to put teams and team members at the center of every project’s successful execution. - January 29, 2014 - EightSpokes
Dr. George Tegos Joins Advisory Board at Peptineo to Guide Antimicrobial Pipeline and Technology Development
Peptineo, a biotechnology company focused on value recovery in Pharma, announces the appointment of George Tegos, PhD, to the company's Scientific Advisory Board. "We are extremely pleased that Dr. Tegos has joined the Peptineo Scientific Advisory Board. Dr. Tegos is recognized as an emerging... - January 29, 2014 - Peptineo
MoBiTec, Germany, Offers Constitutive Gene Expression System for Lactococcus Lactis and Other Lactic Acid Bacteria
The Constitutive Gene Expression System for Lactococcus lactis and Other Lactic Acid Bacteria, developed by NIZO food research BV, The Netherlands, is easy-to operate and has advantages for many applications like overexpression of homologous and heterologous genes. With this new system MoBiTec expands its rich portfolio of non-E. coli vectors and expression systems. - January 19, 2014 - MoBiTec GmbH
Dr. Eric Bachelder Joins Advisory Board at Peptineo
Sheldon K. Jordan, PhD, President and CEO, Peptineo, announces the appointment of Eric Bachelder, PhD, to the company's Scientific Advisory Board. "We are extremely pleased that Dr. Bachelder has joined the Peptineo Scientific Advisory Board. Dr. Bachelder is recognized as an emerging... - January 18, 2014 - Peptineo
Exova Metech Secures Outsourcing Deal with Vestas
Exova Metech, the calibration and metrology division of Exova, the global testing, calibration and advisory services provider, has won an outsourcing deal with the leading wind turbine manufacturer, Vestas, to become its preferred supplier of calibration services. Exova Metech will now acquire the... - January 18, 2014 - Exova
Kimberley Beauford Joins Peptineo as Vice President of Human Capital
Industry veteran and accomplished executive, Kimberley Beauford has joined Peptineo as its new vice president of human capital. Beauford brings over 14 years of proven expertise in the delivery of innovative, strategic human capital programs to the finance and healthcare industries. Prior to... - January 14, 2014 - Peptineo
Cambridge Healthtech Institute Announces Its Inaugural Biologics Formulation & Delivery Summit
Shaping the Future of Delivering Biotherapeutics - What's on the Horizon - January 12, 2014 - Cambridge Healthtech Institute
Creative Biomart Releases New Recombinant Protein Products-Human MET Mutants
Creative Biomart announces that it has launched a series of new recombinant human MET mutants. - January 11, 2014 - Creative Biomart
Creative Diagnostics Launches Its Rapid Malaria Test Kit for Diagnostic Use
As a leading manufacturer and supplier of antibodies and diagnostic components, Creative Diagnostics has launched its innovative malaria testing kit. - January 04, 2014 - Creative Diagnostics
CHI's 5th Annual SCOPE: Summit for Clinical Ops Executives Returns to Miami, February 4-6, 2014
700+ industry executives to gather for solutions on various aspects of clinical trial planning and management at 11 conferences, 7 short courses, breakout discussion groups, networking functions, while also viewing an expansive exhibit hall. - January 02, 2014 - Cambridge Healthtech Institute
OsoBio Reaffirms DCAT Partnership Through New Leadership Positions
OsoBio President Milton Boyer to serve as vice president of DCAT's executive committee. - December 19, 2013 - OSO BioPharmaceuticals Manufacturing, LLC
MiTeGen Announces Online Beamline Guide for Structural Biologists
MiTeGen LLC, a provider of innovative consumables for protein crystallization, crystallography and X-ray diffraction to academic, pharmaceutical, industrial and government researchers around the world, has released an Online Beamline Guide for crystallographers and structural biologists. - December 18, 2013 - MiTeGen, LLC
Leber Hereditary Optic Neuropathy May Benefit from Stem Cell Eye Treatment
MD Stem Cells hopeful that SCOTS stem cell eye study will benefit blinding eye disease caused by damaged energy producing organelles of optic nerve. - December 18, 2013 - MD Stem Cells
Peptineo Inks Exclusive Option for Drug Delivery Technologies
Peptineo, a privately held biotechnology company, announced today that the company has inked an exclusive option for a broad set of nanotechnology patents in the area of drug delivery. Under this agreement, Peptineo will work to commercialize drug delivery technologies developed in the laboratories... - December 10, 2013 - Peptineo
SFL Managing Director Provides Further Update Regarding Revision of EU Medtech Legislation
SFL’s Managing Director, Shayesteh Fürst-Ladani will be giving presentations at two upcoming Swiss life science events on revision of EU Medtech legislation. - November 21, 2013 - SFL Regulatory Affairs & Scientific Communication Ltd
Dr. Emil J. Haldey to Speak Before Medical Society of the State of New York
Dr. Emil J. Haldey, President of New York City-based HALDEY Pharmaceutical Compounding, will speak later this week before an audience of doctors at First District Branch of the Medical Society of the State of New York (MSSNY). MSSNY’s First Branch includes all five boroughs of New York... - November 20, 2013 - HALDEY Pharmaceutical Compounding
Creative Biomart Introduces New Elisa Kits to Offer More Convenient and Effective Solutions
In the early November, Creative Biomart decided to introduce new Elisa Kits which include Developmental proteins ELISA kits, Granzymes and perforins ELISA kits and Growth factors/hormones ELISA kits. - November 20, 2013 - Creative Biomart
Creative Biomart Decides to Pump $300 Million to Strengthen Biosimilar Cell Lines Production
Today on the annual department meeting, Creative BioMart announces that it plans to invest more than $300 million to strengthen its biosimilar cell lines production in global range. The domain sectors of Creative BioMart are recombinant proteins, antibodies and enzymes. Several years ago, the... - November 17, 2013 - Creative Biomart
SFL’s Managing Director to Give Presentation at Informa’s 8th Annual Drug Device Combination Products Event in Berlin
SFL’s Managing Director provides regulatory insight into Drug Device Combination Products in Europe. - November 13, 2013 - SFL Regulatory Affairs & Scientific Communication Ltd
Creative Biomart Announces Commercial Agreement for Services of Biosimilar Cell Lines Manufacturing
Creative Biomart announced today that it has signed a commercial agreement for contract manufacturing pharmaceutical biosimilar cell lines for a big pharma company. - November 10, 2013 - Creative Biomart
VIRUN® & Vital Pharmaceuticals® Expand Operations to Offer a Combined 29 Patents for Raw Material Manufacturing and Finished Product Capabilities
The year 2013 has been a blockbuster renaissance of key partnerships and explosive innovation for VIRUN; early in the year, VIRUN published Chapter 39, Nanotechnology and Nonpolar Active Compounds in Functional Foods through Wiley. In March, Stepan Lipid Nutrition and VIRUN formalized a partnership... - November 05, 2013 - VIRUN
AnaSpec Introduces SensoLyte® 520 TEV (Tobacco Etch Virus) Protease Assay Kit
SensoLyte® 520 TEV (Tobacco Etch Virus) Protease Assay Kit is used for measuring TEV protease quantity and activity. TEV protease is widely used to remove fusion tags from recombinant proteins. - November 01, 2013 - AnaSpec, EGT Group
AveXis-BioLife Launch New Website
AveXis-BioLife is pleased to announce the launch of the company’s brand new website: www.avexisinc.com. The October 2013 unveiling of the website coincides with the company’s licensing of the gene therapy program from The Kaspar Laboratory for the treatment of Spinal Muscular Atrophy... - November 01, 2013 - AveXis Inc.
Empire Genomics and QuaDPharma Join Forces for Cancer Research Fundraiser
Two Buffalo-area CEOs roll up their sleeves to serve the community and give where they live. - October 31, 2013 - Empire Genomics
AveXis-BioLife Licenses Spinal Muscular Atrophy (SMA) Patent Portfolio from Nationwide Children's Hospital and The Ohio State University
BioLife, a synthetic biology platform company soon to be renamed AveXis, has been granted exclusive rights to the spinal muscular atrophy gene therapy program developed at The Research Institute at Nationwide Children’s Hospital and The Ohio State University in Columbus, Ohio. The license... - October 21, 2013 - AveXis Inc.
Creative Biomart Releases New Products in the Middle of Oct.
In the middle of Oct., Creative Biomart releases a new batch a products, including: Ÿ Recombinant Human MUSK, GST-tagged Ÿ Recombinant Human TIRAP, His-tagged Ÿ Native Mouse Hb Ÿ Recombinant Human NCAM2, GST-tagged Ÿ Recombinant Human NBPF15, His-tagged Ÿ Recombinant... - October 19, 2013 - Creative Biomart
Microfluidics Startup NanoCellect Adds Strategic Advisors and Nabs Another $700K from the NIH
NanoCellect, (previously called NanoSort) aims to facilitate breakthrough biomedical discoveries by making cell analysis and sorting technology more affordable and easier to use. Spunout from UCSD in late 2009, NanoCellect has now raised over $3.3M including a new $700K grant to continue developing... - October 19, 2013 - NanoCellect
AveXis BioLife Announce The Research Institute at Nationwide Children’s Hospital Received Fast Track Status for Spinal Muscular Atrophy Treatment
AveXis and BioLife, synthetic biology platform companies, today announced that The Research Institute at Nationwide Children’s Hospital received Fast Track designation from the U.S. Food and Drug Administration for its scAAV9.CB.SMN gene therapy product for the treatment of spinal muscular... - October 18, 2013 - AveXis Inc.
Mini-Gastric Bypass Performed with SPIDER® Surgical System
Internationally respected surgeon Dr. Michel Gagner completed procedure using fewer incisions. - October 10, 2013 - TransEnterix
MD Stem Cells Indicates Government Shutdown Will Not Impact SCOTS Eye Stem Cell Treatment Study
MD Stem Cells sees no immediate effect on the SCOTS eye stem cell trial but is monitoring NIH throughout the government shutdown. - October 03, 2013 - MD Stem Cells
HALDEY Pharmaceutical Compounding President to Address Brooklyn Physicians on Oct. 2
Dr. Emil J. Haldey will speak before an audience of doctors at the Medical Society of the County of Kings, in association with the Academy of Medicine of Brooklyn. - October 01, 2013 - HALDEY Pharmaceutical Compounding
The Changing Environment for Pharma and Medtech Companies in Europe
SFL Regulatory Affairs Consulting Ltd. (SFL) is pleased to be strengthening its activities in the UK and will be holding an inaugural and networking event in London on 8 October 2013. - September 30, 2013 - SFL Regulatory Affairs & Scientific Communication Ltd
Creative Biomart is Going to Sign Luciferase Supply Agreement with Kasain Laboratory
After a long-term contact and discussion, Creative Biomart finally agrees to sign a Luciferase supply agreement with Kasain Laboratory, especially Native Vibrio fischeri Luciferase (http://www.creativebiomart.net/description_390631_24.htm) until Kasain finishes its study projects. The official... - September 22, 2013 - Creative Biomart
SignaBlok Achieves Key in Vivo Proof of Concept for Treatment of Cancer and Sepsis
Novel First-in-Class Peptide Inhibitor of TREM-1 Modulates the Inflammatory Response and Shows Promise for Treatment of Cancer and Sepsis - September 18, 2013 - SignaBlok, Inc.